School of Pharmacy - News

The Finnish Research Impact Foundation’s new funding scheme gives professors the opportunity to spend one year working on their research with an industry partner, in an industry environment.

Researchers at the School of Pharmacy developed a new method for the accurate determination of the water content of water-soluble compounds. This plays a significant role in, e.g., drug dosage.

The U.S. Food and Drug Administration, FDA, has granted research funding to too ocular drug projects.

For the first time ever, researchers used the transporter protein OATP1C1, which is found in the brain, to enhance drug delivery into the brain, and especially into glial cells.

UEF and partners received over 3.2 million euros in development funding from various instruments.

A recent visit to Ghana by a UEF delegation witnessed the signing of two memoranda of understanding on education and research collaboration.

In vitro and in vivo methodologies were employed to investigate ocular drug metabolism across species and ocular tissues.

Tetsuya Terasaki has opened a new research field of pharmacoproteomics, which is expected to play an important role in the progress of the pharmaceutical and biomedical sciences in the next decade.

Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules.

The Finnish Research Impact Foundation (FRIF) has granted 2.1 million euros of funding to joint research projects between universities and corporate partners.